Current Requirements for Assessment of Elemental Impurities (Heavy Metals) in Medicines


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

One element of ensuring the quality and safety of medicines consists of normalizing and controlling elemental impurities (heavy metals). The sources and causes of the presence of elemental impurities (heavy metals) in medicines are discussed. Changes in approaches to assessment of elemental impurities in medicines in the State Pharmacopeia and leading non-Russian pharmacopeias are discussed. A risk-oriented approach to assessing elemental impurities used in international practice is presented.

About the authors

E. L. Kovaleva

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

A. I. Belanova

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

L. I. Panova

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051

A. A. Zakharchenko

Scientific Center for Expert Assessment of Medicines, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Russian Federation, Building 2, 8 Petrovskii Boulevard, Moscow, 127051


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies